MML Investors Services LLC acquired a new stake in Smith & Nephew plc (NYSE:SNN – Free Report) in the 3rd quarter, Holdings Channel reports. The firm acquired 7,862 shares of the medical equipment provider’s stock, valued at approximately $245,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brandes Investment Partners LP grew its holdings in Smith & Nephew by 20.5% in the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock valued at $34,002,000 after purchasing an additional 233,293 shares during the last quarter. River Road Asset Management LLC purchased a new position in Smith & Nephew during the 3rd quarter valued at about $38,588,000. Bank of Montreal Can raised its position in Smith & Nephew by 355.8% during the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after acquiring an additional 964,762 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Smith & Nephew by 18.9% in the second quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider’s stock valued at $13,607,000 after purchasing an additional 87,360 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of Smith & Nephew by 58.2% in the second quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock valued at $12,995,000 after purchasing an additional 193,046 shares during the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research firms recently issued reports on SNN. StockNews.com lowered Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, November 12th. Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th.
Smith & Nephew Stock Performance
Shares of SNN opened at $24.44 on Thursday. The company has a market capitalization of $10.68 billion, a price-to-earnings ratio of 12.47, a PEG ratio of 1.41 and a beta of 0.84. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. Smith & Nephew plc has a 1 year low of $23.65 and a 1 year high of $31.72. The company’s 50 day simple moving average is $26.05 and its 200 day simple moving average is $27.87.
About Smith & Nephew
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Stories
- Five stocks we like better than Smith & Nephew
- What is the Dow Jones Industrial Average (DJIA)?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What Are Trending Stocks? Trending Stocks Explained
- 2 Drone Stocks Surging from Increased Media Attention
- 3 Warren Buffett Stocks to Buy Now
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN – Free Report).
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.